Skip to main content
BioMed Research International logoLink to BioMed Research International
. 2019 Mar 3;2019:5673740. doi: 10.1155/2019/5673740

Corrigendum to “A Novel Curcumin-Galactomannoside Complex Delivery System Improves Hepatic Function Markers in Chronic Alcoholics: A Double-Blinded, randomized, Placebo-Controlled Study”

Naveen T Krishnareddy 1,, Justin V Thomas 2, Saritha S Nair 3, Johannah N Mulakal 3, Balu P Maliakel 3, I M Krishnakumar 3
PMCID: PMC6421028  PMID: 30941366

In the article titled “A Novel Curcumin-Galactomannoside Complex Delivery System Improves Hepatic Function Markers in Chronic Alcoholics: A Double-Blinded, randomized, Placebo-Controlled Study” [1], the dosage of drugs in the Materials and Methods and Results was given incorrectly as (250 mg x 1)/ day. It should be corrected to (250 mg x 2)/ day.

References

  • 1.Krishnareddy N. T., Thomas J. V., Nair S. S., Mulakal J. N., Maliakel B. P., Krishnakumar I. M. A novel curcumin-galactomannoside complex delivery system improves hepatic function markers in chronic alcoholics: A double-blinded, randomized, placebo-controlled study. BioMed Research International. 2018;2018:10. doi: 10.1155/2018/9159281.9159281 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BioMed Research International are provided here courtesy of Wiley

RESOURCES